Clearside Biomedical shares up 12% in market debut

Shares of Clearside Biomedical Inc. were up 12% in midday trade Thursday in the company’s debut on the Nasdaq. Shares were trading at $7.85, above the company’s $7 issue price. The company sold 7.2 million shares to raise $50.4 million. Cowen and Company and Stifel were the lead underwriters.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Leave a Reply